| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.001 |